Showing 1 posts of 1 posts found.
Canadian biotech MedGenesis has entered into an agreement with Pfizer to develop potential treatments for Parkinson’s disease. The privately-held biotech …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO